Allianz Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Allianz Asset Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35,250	Closed	-$677K	–	2343
2020 Q4	$677K	Sell	35,250 -7,500	-18%	-$116K	﹤0.01%	1571
2020 Q3	$574K	Buy	+42,750	New	+$1.21M	﹤0.01%	1577
2020 Q1	–	Sell	-39,923	Closed	-$1.29M	–	2816
2019 Q4	$1.29M	Buy	39,923 +1,197	+3%	+$37.1K	﹤0.01%	2079
2019 Q3	$1M	Sell	38,726 -15,187	-28%	-$508K	﹤0.01%	2128
2019 Q2	$1.98M	Sell	53,913 -28,033	-34%	-$672K	﹤0.01%	1891
2019 Q1	$1.81M	Sell	81,946 -81,127	-50%	-$1.42M	﹤0.01%	1874
2018 Q4	$2.3M	Sell	163,073 -81,087	-33%	-$1.26M	﹤0.01%	1720
2018 Q3	$4.74M	Sell	244,160 -430	-0.2%	-$8.77K	﹤0.01%	1580
2018 Q2	$5.4M	Buy	244,590 +560	+0.2%	+$13K	0.01%	1491
2018 Q1	$5.17M	Buy	244,030 +495	+0.2%	+$11.7K	﹤0.01%	1523
2017 Q4	$6.09M	Buy	+243,535	New	+$5.75M	﹤0.01%	1540

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Allianz Asset Management's ODT Position: Q1 2021 in Review

Allianz Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 35,250 shares — an estimated $677K sold.

Allianz Asset Management first reported a position in ODT in Q4 2017 and held it in 11 quarters. The position peaked at $6.09M in Q4 2017. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

Allianz Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Allianz Asset Management sold 35,250 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $677K.
Allianz Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 11 quarters.
Allianz Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $6.09M in Q4 2017.
83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.